Brian James Miller, M.D., M.B.A., M.P.H.

Headshot of Brian James Miller
  • Assistant Professor of Medicine


Hospitalist, Internal Medicine, Preventive Medicine more

Research Interests

Payment Policy; FDA Regulatory Policy; Healthcare Competition Policy more


The Johns Hopkins Hospital

600 N. Wolfe Street
Baltimore, MD 21287
Phone: 410-614-4474 | Fax: 410-367-2770
The Johns Hopkins Hospital - Google Maps


Dr. Miller is a practicing hospitalist, health policy researcher, and health policy analyst. He serves as an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine and an Assistant Professor (courtesy) at the Johns Hopkins Carey Business School. His research focuses on payment policy, FDA regulatory pathways, and healthcare competition policy.

Dr. Miller previously served as a Medical Officer in the Office of New Drugs at the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, where he focused on pre- and post-market safety regulation, including the review and approval of valbenazine, a first-in-class breakthrough new molecular entity. He also served as a Senior Policy Fellow for Health IT at the Federal Communications Commission, in addition to serving as a Special Advisor in the Federal Trade Commission's Office of Policy Planning. At the FTC, he worked on competition policy and served as an in-house physician expert for the Bureau of Competition, assisting in merger review and enforcement in health systems, pharmaceuticals, and retail drug stores, including the FTC's successful action blocking the $7 billion Advocate - NorthShore merger. Prior to the FTC, Dr. Miller was a Fellow at the Centers for Medicare & Medicaid Innovation, where he co-managed the ACO Investment Model, a $114 million project focused on ACOs in rural areas.

He is currently a member of the Medicare Evidence Development & Coverage Advisory Committee and a consultant to government agencies. more


  • Assistant Professor of Medicine

Departments / Divisions

Centers & Institutes



  • MD; Northwestern University Feinberg School of Medicine (2011)


  • Preventive Medicine; Johns Hopkins Bloomberg School of Public Health (2016)
  • Internal Medicine; MedStar Health (2020)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (2020)
  • American Board of Preventive Medicine (Public Health & Gen Preventive Med) (2017)

Research & Publications

Research Summary

Dr. Miller's research focuses on the intersection of healthcare and the state: healthcare competition policy, health insurance program design, and the FDA regulation of drugs, devices, and tobacco products. Applied in nature, his research is conducted in partnership with academics, federal regulators, corporations, and policymakers.

Dr. Miller's goal is to understand how competition can drive increased productivity, lower costs, and improve quality in insurance and care delivery markets. Secondly, he explores how merger control policy affects cost, quality, and consumer experience. Finally, he aims to understand how FDA regulatory pathways for drugs, devices, and tobacco products can be redesigned to promote the public health and support cost-effective clinical practice.

Selected Publications

Miller BJ, Wolfe G Managed Care Marketplaces: Growing Drivers of Payer-Provider Vertical Integration, Antitrust Source April 2017;16(5):1-11

Davis MC, Miller BJ, Kalsi J, Birkner T, Mathis MV. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia. The New England Journal of Medicine 2017;376:2503-2506

Miller BJ, Slota J, Ehrenfeld JM Redefining the Physician’s Role in Cost Conscious Care JAMA 2019;322(8):721-722

Meshnick A, Miller BJ, Lushniak BD How FDA Can Act On E-Cigarettes And Protect The Public Health. Health Affairs Blog September 17, 2019

Miller BJ, Zima S. Exceptions for Exceptional Cures: Modernizing the Medicaid Drug Rebate Program. JAMA Health Forum August 31, 2020

Is this you? Edit Profile
back to top button